SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 12)
Survival Technology, Inc.
(Name of Issuer)
Common Stock, Par Value $.10 per Share
(Title of Class of Securities)
869028100
(CUSIP Number)
Robert E. Herzstein, Esq.
801 Pennsylvania Ave. N.W.
Washington, D.C. 20004-2604, (202) 508-8030
(Name, Address, and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 15, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Sched-
ule 13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of Rule 13d--
1(b)(3) or (4), check the following box.[ ]
Check the following box if a fee is being paid with this state-
ment [ ].<PAGE>
1 Name of Reporting Person
ROBERT E. HERZSTEIN
S.S. or I.R.S. Identification No. of above Person
###-##-####
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [x]
3 SEC Use Only
4 Source of Funds
Not applicable
5 Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
United States
7 Sole Voting Power
40,550 shares of Common Stock
Number of
Shares 8 Shared Voting Power
Beneficially -0-
Owned By
Each 9 Sole Dispositive Power
Reporting 40,550 shares of Common Shares
Person With
10 Shared Dispositive Power
-0-
11 Aggregate Amount Beneficially Owned by Each Reporting Person
40,550 shares of Common Stock
12 Check Box if the Aggregate Amount in Row (11) Excludes
Certain Units [ ]
13 Percent of Class Represented by Amount in Row (11)
Approximately 1.2%
14 Type of Reporting Person
IN
-2-<PAGE>
This Statement is Amendment No. 12 to the Statement
on Schedule 13D filed June 11, 1990 with the Securities and
Exchange Commission (the "Commission"), as amended by Amendment
No. 1 filed October 22, 1990, Amendment No. 2 filed March 8,
1993, Amendment No. 3 filed April 14, 1993, Amendment No. 4
filed August 5, 1993, Amendment No. 5 filed October 4, 1993,
Amendment No. 6 filed December 1, 1993, Amendment No. 7 filed
March 3, 1994, Amendment No. 8 filed March 9, 1994, Amendment
No. 9 filed May 27, 1994, Amendment No. 10 filed November 22,
1994, and Amendment No. 11 filed March 19, 1996 in connection
with Robert Herzstein's beneficial ownership of shares of com-
mon stock of Survival Technology, Inc., a Delaware corporation
(the "Issuer"), which has its principal executive offices at
2275 Research Boulevard, Rockville, Maryland 20850. Pursuant
to Rule 101(a)(2)(ii) of Regulation S-T, this Schedule 13D has
been amended and restated in its entirety.
ITEM 1. SECURITY AND ISSUER.
This Statement relates to the Common Stock, par value
$0.10 per share (the "Common Stock"), of Survival Technology,
Inc., a Delaware corporation (the "Issuer"), which has princi-
pal executive offices at 8101 Glenbrook Road, Bethesda, Mary-
land 20814.
ITEM 2. IDENTITY AND BACKGROUND.
This Statement is being filed by Robert E. Herzstein,
whose principal occupation is as an attorney at Shearman &
Sterling, 1001 30th Street N.W. Suite 400, Washington, D.C.
20007.
Mr. Herzstein has not been convicted in any criminal
proceeding (excluding traffic violations or similar misdemean-
ors) during the last five years.
Mr. Herzstein has not been a party to a civil pro-
ceeding of a judicial or administrative body of competent ju-
risdiction in which, as a result of such proceeding, he was or
is subject to a judgment, decree or final order enjoining fu-
ture violations of, or prohibiting or mandating activities sub-
ject to, federal or state securities laws or finding any vio-
lation with respect to such laws during the last five years.
Mr. Herzstein is a citizen of the United States.
-3-<PAGE>
ITEM 3. SOURCE OR AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Not applicable.
ITEM 4. PURPOSE OF THE TRANSACTION.
Robert Herzstein, Personal Representative of the Es-
tate of Dr. Stanley J. Sarnoff (the "Estate") and Brunswick
Biomedical Corporation, a Massachusetts corporation ("Brun-
swick") entered into a Stock Purchase Agreement dated as of
March 18, 1996 (the "Agreement"). Pursuant to the Agreement,
Brunswick agreed to purchase 1,888,126 shares of Common
Stock of the Issuer from the Estate (the "Stock Purchase") in
exchange for $16,069,386 in cash, a subordinated promissory
note in the original principal amount of $4,700,000 (the
"Note") and warrants to purchase 50,000 shares of common stock
of Brunswick (which, if exercised, would represent ap-
proximately 5% of the outstanding shares of common stock of
Brunswick on a fully diluted basis), at an exercise price of
$27.55 per share.
Copies of the Stock Purchase Agreement, the Note and
the Warrant were filed as exhibits to Amendment No. 11, and are
hereby incorporated herein by reference. The foregoing de-
scription is qualified in its entirety by reference to such
exhibits.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
On April 15, 1996, the Stock Purchase was consummated
pursuant to the Agreement. Following consummation of the Stock
Purchase, Mr. Herzstein retains beneficial ownership of a total
of 40,550 shares of Common Stock as follows: (i) the Estate of
Stanley J. Sarnoff (the "Estate") of which Mr. Herzstein is
personal representative, continues to hold options to acquire
32,500 shares of Common Stock granted pursuant to the Option
Agreement dated as of September 14, 1990 made by the Issuer in
favor of the Estate, as amended effective as of September 14,
1993, which options were not transferred as part of the Stock
Purchase, (ii) Mr. Herzstein continues to hold options to ac-
quire 6,000 shares of Common Stock granted by the Issuer to Mr.
Herzstein on July 9, 1990, under the Issuer's 1986 Stock Option
Plan, (iii) Mr. Herzstein continues to hold 1,050 shares of
Common Stock, and (iv) Sarnoff family trusts, of which Mr.
Herzstein is sole trustee, hold 1,000 shares of Common Stock.
-4-<PAGE>
On April 15, 1996, as a result of the consummation of
the Stock Purchase, Mr. Herzstein ceased to be the beneficial
owner of more than 5% of the Common Stock of the Issuer.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONS
WITH RESPECT TO SECURITIES OF THE ISSUER.
The Option Agreement, described in Item 5. provides
for the issuance by the Issuer of 32,500 shares of Common Stock
upon the exercise of the options held by the Estate, described
above.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 1: Stock Purchase Agreement, dated as of March
18, 1996, between Brunswick Biomedical Corporation and the Es-
tate of Dr. Stanley J. Sarnoff, Robert Herzstein as Personal
Representative.*
Exhibit 2: Form of Note.*
Exhibit 3: Form of Warrant.*
* Filed as exhibits 1, 2, and 3 with Amendment No. 11.
-5-<PAGE>
Signature
After reasonable inquiry and to the best of my knowl-
edge and belief, I certify that the information set forth in
this statement is true, complete and correct.
/s/ Robert E. Herzstein
Robert E. Herzstein
Dated: April 15, 1996
-6-
